A comparison of fibrosis progression in chronic liver diseases. - Wikidata - wikimedia - TriplyDB

A comparison of fibrosis progression in chronic liver diseases.

A comparison of fibrosis progression in chronic liver diseases.

http://www.wikidata.org/entity/Q44314885

about

The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis Involvement of matrix metalloproteinases (MMPs) and inflammasome pathway in molecular mechanisms of fibrosis Telomeres, NAFLD and Chronic Liver Disease Multidisciplinary View of Alcohol Use Disorder: From a Psychiatric Illness to a Major Liver Disease Role of liver transplantation in human immunodeficiency virus positive patients Update on Alcoholic Hepatitis Diagnosis and Management of Alcoholic Liver Disease Perinatal exposure to a high-fat diet is associated with reduced hepatic sympathetic innervation in one-year old male Japanese macaques The Role of Obstetrician/Gynecologists in the Management of Hepatitis C Virus Infection New Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review Article State-of-the-art imaging of liver fibrosis and cirrhosis: A comprehensive review of current applications and future perspectives Hepatocyte IKK2 protects Mdr2-/- mice from chronic liver failure Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data Attenuating effect of Ginkgo biloba leaves extract on liver fibrosis induced by thioacetamide in mice A new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis B Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver Liver fibrosis and protection mechanisms action of medicinal plants targeting apoptosis of hepatocytes and hepatic stellate cells Liver fibrosis and mechanisms of the protective action of medicinal plants targeting inflammation and the immune response.Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus Validation of AshTest as a Non-Invasive Alternative to Transjugular Liver Biopsy in Patients with Suspected Severe Acute Alcoholic Hepatitis.Diagnosis of alcoholic liver disease.Assessment of hepatic fibrosis regression by transient elastography in patients with chronic hepatitis B treated with oral antiviral agents Meta-analyses of FibroTest diagnostic value in chronic liver disease.Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study.Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much?German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients.Hepatitis C: is a vaccine the solution?Estrogen receptor alpha gene polymorphisms and risk of HBV-related acute liver failure in the Chinese population Effects of β-sitosterol derived from Artemisia capillaris on the activated human hepatic stellate cells and dimethylnitrosamine-induced mouse liver fibrosis Associations of IFN-γ rs2430561 T/A, IL28B rs12979860 C/T and ERα rs2077647 T/C polymorphisms with outcomes of hepatitis B virus infection: a meta-analysis.Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection.Willingness to undergo a repeat liver biopsy among HIV/hepatitis C virus-coinfected and hepatitis C virus-monoinfected patients.Interleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problems PNPLA3 I148M (rs738409) genetic variant and age at onset of at-risk alcohol consumption are independent risk factors for alcoholic cirrhosis.qFibrosis: a fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease.Cystatin C and creatinine in an HIV cohort: the nutrition for healthy living study.Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index.An appraisal of the histopathological assessment of liver fibrosis

P2860

Q25257576-99A3A2AA-6065-4199-A593-5440ABC76C82 Q26744390-A27EC4C4-4286-4B3D-9184-829BA9364F45 Q26753037-B311B63C-45CA-46A5-89A4-290D26B35463 Q26771090-84E33D25-9393-47C3-816F-631BA4C74527 Q26775931-DC9E351B-677D-4324-A00A-8232CE3EB8B9 Q26779121-C0B4C4F6-9F0C-4A41-A37C-2E346F0FE212 Q26781876-981E9A1B-AB31-411D-9526-9759BECF692D Q27312641-8061D7AD-4216-433C-BC7C-11D346E427D6 Q27486939-975F760F-651E-4BCD-8F6E-98497B3FB73E Q28070168-07E5BE02-5FF2-447B-96F6-095908F87D76 Q28085479-2D140CDE-E835-42B7-90A2-AE190F3E837E Q28477512-AAE8C2C3-47E0-436E-9229-BBD3120B2D7B Q28481485-099812B7-F4D8-47AD-A91A-56395A519C6C Q28727196-01525FFA-BFCE-4A08-866D-4CC50C23C4B1 Q28741501-875C203E-4DA6-410D-BC5C-59B7F2C49249 Q29616840-6B0421C6-F957-420D-BF55-2D7E0496EB15 Q30369750-8A186EB8-69D3-454E-AFFE-D736B8AB0D34 Q30374500-137E58E8-203B-4CFE-BD40-7219249B52E3 Q30375738-DD95542A-A712-4A31-8D0D-F682FAD5FB72 Q30404990-A3DE83FF-C949-40AA-838A-E407E9BFDA15 Q30431186-E1C0A652-F095-4CCD-BECD-7A41CBCAC13C Q30439873-98D43366-7F2F-4A3D-BE49-8E1B68A9D5FA Q33302708-93999649-1968-435B-903B-827D33551A64 Q33562288-28F3EEE7-71ED-4354-B1B5-356F9FAA512E Q33787655-2882B4D2-BFC6-478A-B584-EE2FBEB0BAEC Q33840930-73730FA9-B42B-4DBA-9172-2C1C27D9AAC5 Q33863006-467CEED2-803D-4103-B03B-1BEB9647E719 Q34290831-7AB549EE-5AC8-4EC3-9112-C8FBB179CC74 Q34315221-698571A4-71B5-44EF-926A-DD1C7DCF0572 Q34320250-2A95FB40-3BF2-42E4-BB6D-B5C4E74A24E4 Q34604379-C08AB468-0587-4591-8422-0C672FC62102 Q34606036-C2AFA751-B480-4DB7-98FD-ED9168FE7EE7 Q34670502-4F432860-9151-4538-BD60-E3DE03295AD5 Q34677793-C505A71D-1404-4D53-A08E-3D17B8F10E24 Q34693476-FF412AE3-7AAB-4F79-889E-08FF81F099DF Q34785127-4F67FD78-448B-4770-946B-BB55E5644F53 Q34893571-7B53AD9C-0D36-4170-8455-CDDBA37C537F Q35604023-1070F9D4-CA6A-4E50-8754-8AD6BED74D63 Q35668307-F9069F55-64D4-447F-B78C-EF539ECFB4CF Q35760393-B17F0675-3C7E-4593-A39C-0E4CE450D3BE

P2860

A comparison of fibrosis progression in chronic liver diseases.

http://www.wikidata.org/entity/Q44314885

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

A comparison of fibrosis progression in chronic liver diseases.

@en

A comparison of fibrosis progression in chronic liver diseases.

@nl

type

label

A comparison of fibrosis progression in chronic liver diseases.

@en

A comparison of fibrosis progression in chronic liver diseases.

@nl

prefLabel

A comparison of fibrosis progression in chronic liver diseases.

@en

A comparison of fibrosis progression in chronic liver diseases.

@nl

P1433

Q44314885-9FF97A8A-0020-4DA9-B4ED-010FD1BA2ADC

P1476

Q44314885-D59AFA95-B696-41D6-BFDB-168BAEA16837

P2093

Q44314885-41633D4B-8167-4FF3-B76E-31E244B9E697

Q44314885-48012139-055E-4B14-8FCB-4B807A835EB2

Q44314885-6556D8E3-566C-4A66-928B-D92F32C4D4B8

Q44314885-6B2AA15B-5FD7-4917-A23C-47D476E7E93A

Q44314885-7CFA461B-E184-49D3-9B04-ACEA69392335

Q44314885-8171C6A9-FC36-4012-94ED-A068B7DA14BC

Q44314885-874161BA-E6C4-4721-956F-8A2D258A7043

Q44314885-962DA572-C955-4413-9DF0-CCBD2C1303D8

Q44314885-D0F2E30C-EBBD-402E-AA73-376BA3DEBDC0

Q44314885-FCA852F3-5AE2-454D-A91B-B795679672DB

P304

Q44314885-A080A1B2-8B4D-4D9A-957A-1E630C9E5A6B

P31

Q44314885-E0D78A71-529D-45A7-A629-45645FCEEDC9

P356

Q44314885-5032C610-B046-48D7-8413-B6AE135F9DF4

P433

Q44314885-1A840D18-A9D2-4538-A3D8-B9D1B6A96591

P478

Q44314885-93B0D944-753E-4FFB-8A7B-04B120D19187

P50

Q44314885-27298AE6-D455-406E-9BE9-89D745F3FAC1

Q44314885-48A0DBB0-35C2-4261-A087-14DB9271CEBC

Q44314885-6BAB4894-0126-4993-89D7-B9F4988600B6

Q44314885-7CC40949-8FD2-47CD-B03C-56B40B18536E

Q44314885-81623FDD-01D0-4B7E-9AF9-E13D31FA3E99

P577

Q44314885-7DE3B694-3FD8-4850-869E-3B09A1FF4F59

P5875

Q44314885-A9C43221-02B5-42D0-82C9-B99EBB1FBE49

P698

Q44314885-B5598C1B-5FEA-43BC-9D97-850F7CA84648

P356

S0168-8278(02)00413-0

P1433

Journal of Hepatology

P1476

A comparison of fibrosis progression in chronic liver diseases.

@en

P2093

Antonio Chedid

http://www.w3.org/2001/XMLSchema#string

Arndt Vogel

http://www.w3.org/2001/XMLSchema#string

Frédérique Capron

http://www.w3.org/2001/XMLSchema#string

Marie-Hélène Tainturier

http://www.w3.org/2001/XMLSchema#string

Michael Manns

http://www.w3.org/2001/XMLSchema#string

Mona Muntenau

http://www.w3.org/2001/XMLSchema#string

PANFIBROSIS Group

http://www.w3.org/2001/XMLSchema#string

Renée Poupon

http://www.w3.org/2001/XMLSchema#string

Robert P Myers

http://www.w3.org/2001/XMLSchema#string

Vlad Ratziu

http://www.w3.org/2001/XMLSchema#string

P304

257-265

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0168-8278(02)00413-0

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P50

Dominique Guyader

Thierry Poynard

Philippe Mathurin

P577

2003-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10901313

http://www.w3.org/2001/XMLSchema#string

P698

12586290

http://www.w3.org/2001/XMLSchema#string